PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAYS.
In FY 09 AMREF will continue to provide oversight and trainings in rapid HIV test , CD4, Chemistry and
Hematology training for the new care and treatment sites as well as facility level laboratory management
trainings. AMREF will work with laboratory focal persons of the care and treatment partners in their
respective regions and trainers from PMTCT, CT, TB/HIV programs to ensure that the on going HIV rapid
tests training for laboratory and non laboratory health care workers meets the required standards. With
the increase in the accessibility for HIV testing through the TB/HIV, Counseling and Testing, PMTCT
programs and the new Provider Initiated Testing and Counseling Strategy, the number of health workers
involved in performing rapid test is going to increase tremendously. To ensure confidence in the results
generated from all these testers, there is a need to provide a very rigorous quality assurance protocol for all
testing sites as proposed in the WHO/CDC guidelines for rapid HIV testing. AMREF will conduct supportive
supervisory visits of laboratories and testing sites and build a network of supervisors at all levels of HIV
testing. AMREF will assist MOHSW define and implement an HIV serology quality assurance scheme that
will focus on quality of training, onsite monitoring, proficiency panel administration and limited retesting of
samples at the regional hospital laboratories and the National Health Laboratory Quality Assurance and
Training Centre. AMREF will collaborate with the MOHSW and National Medical Laboratory Technologists
Council to ensure certification of all non laboratory health care workers performing rapid HIV testing.
AMREF will continue to support care and treatment partners in training health workers for early infant
diagnosis. END ACTIVITY MODIFICATION
TITLE: Strengthening Laboratory Capacity to Support HIV/AIDS Prevention, Care and Treatment
NEED and COMPARATIVE ADVANTAGE: The National HIV/AIDS Care and Treatment Plan for 2003-2008
targets expansion of care and treatment centers to 200 sites located in public, private, and faith-based
organization health facilities countrywide. The plan set to provide ART to approximately 440,000 people by
2008. With a 7% HIV prevalence in the general population, and assuming 20% would be treatment-ready,
five million people will need to be tested to find 100,000 ARV treatment-ready individuals. At many of these
entry points, HIV rapid testing will be performed by non-laboratory health workers to scale up identification
of HIV positive individuals. Laboratory personnel will supervise testing at key ART entry sites. AMREF,
winner of the 1999 Conrad N. Hilton Humanitarian Award and the 2005 Gates Award for Global Health, has
technical expertise in HIV/AIDS and health training. AMREF, through the ANGAZA Voluntary Counseling
and Testing (VCT) and Prevention of Mother-to-Child Transmission (PMTCT) programs, took the lead in the
training of non-laboratory health workers for HIV rapid testing, a model now scaled up nationwide, and an
integral component of the recent National Testing Campaign launched by The President on July 14, 2007.
AMREF will use their experience in training laboratory personnel to support the Ministry of Health with
logistics in the roll out to lower level facilities for training on CD4, Chemistry and Hematology testing.
ACCOMPLISHMENTS: AMREF facilitated the zonal-level training of 746 health workers - 336 (45%)
laboratory staff and 410 (55%) non-laboratory staff - in HIV rapid testing and the new National HIV rapid
testing algorithms, with the assistance of trained trainers, and support from the MOHSW and the National
Training Team .
ACTIVITIES : The activities for FY 2008 will focus on continued training and quality assurance on the HIV
rapid test, collaboration with MOHSW, laboratory partners and the National Laboratory Training Team to
facilitate training of laboratory and non-laboratory health workers in HIV rapid testing to meet the set target
of 1000. AMREF will undertake retraining of laboratory and non-laboratory health care workers, including
additional requirements at National level training using trained zonal trainers for rapid HIV testing and will
procure test kits and supplies needed to support the on-going laboratory-training program in HIV rapid
testing, and CD4, Chemistry and Heamatology testing to cater for expansion to additional care and
treatment sites.
AMREF will support HIV rapid testing quality assurance activities to monitor performance of trainees at their
places of work to ensure compliance to programme and MOHSW set standards. Existing supervision
matrix and tools will be applied to two selected laboratories and Counseling and Testing (CT) sites per
region. The activities include quality assurance of sample testing and competency assessment of those
performing the tests. This will involve on-site retesting of the first 50-100 samples performed by the testers,
conducting remedial and/or corrective actions, and performing continuous site quality assessments. At
these visits proficiency panel testing will also be conducted. AMREF willl support on-site support
supervision and training at testing sites to assess competency and to certify that trainees are using the
standard operational procedures according to the MOHSW training curriculum and CDC/WHO criteria;
convene program review meetings, and support attendances for laboratory personnel to conferences and
study tours, as appropriate. Lesson learned will be shared with MOHSW, the sites and stakeholders and
will be used to modify project implementation. Rapid testing training and monitoring of trained staff will be
a continued activity. AMREF will work with the MOHSW to continue to ensure that these activities remain
effective in responding to their goals. These activities are geared to ensure accessible, accurate and
reliable diagnosis of HIV by rapid testing and availability of reliable monitoring testing for HIV/ AIDS care
and treatment
LINKAGES: AMREF works closely with the MOHSW and Care and Treatment, other non USG development
partners. To ensure development of sustainable laboratory services, avoid duplication of activities, and
maximize resources, AMREF attends the MOHSW quarterly meetings in which laboratory partners present
their progress, achievements, challenges, and a way forward. Regular meetings convened by CDC for the
PEPFAR laboratory partners are another link to ensure that efforts are coordinated and not duplicated in
supporting MOHSW to implement activities. The project links its activities with the National Care and
Treatment programmes, such as PMTCT, VCT, TB, STI, Home-based care and palliative care programme
through training of in-services providers. AMREF will work under the national guidelines and plans for
implementation.
Activity Narrative: CHECK BOXES: The overall strategy of the project is to train both laboratory and non-laboratory personnel
to improve the quality of HIV rapid diagnostics laboratory tests; train the health management team in a
supervisory system for effective monitoring and strengthening of rapid HIV testing services, and increase
identification of HIV positive individuals in order to meet the national targets for ART These will be achieved
through training, quality assurance and supportive supervision. About 1000 laboratory and non - laboratory
health care workers will be trained to perform tests according to standards will be trained to perform rapid
HIV testing.
M&E: A project monitoring and evaluation framework will be used to monitor the project's outputs and
expected outcomes during the project lifetime.
The M&E tool to capture data on whether the project is achieving desired goal for training as the number
trained, percentage sites demonstrating quality indicators, number and category of service providers
trained, competent testers certified, types of supplies procured; number of laboratorians trained on CD4,
chemistry and hematology testing, external quality assessment results for sites trained, number of
supervisions conducted.
SUSTAINAIBLITY: AMREF works with the Diagnostic Services section of the MOHSW and is a member of
the National training team which implements the in-service training strategy. Training of trainers and
supervisors ensures local capacity and roll out plans and will enable quick adoption of best practices.
Inclusion of PMTCT, CT, TB/HIV and other programs will ensure comprehensive planning, standardization
of training and inclusion of laboratory training in program specific training. To enable replication of the model
elsewhere, AMREF will work with MOHSW and partners on agreed criteria for identification of best
practices.
New/Continuing Activity: Continuing Activity
Continuing Activity: 13427
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
13427 3455.08 HHS/Centers for African Medical 6490 1217.08 $475,000
Disease Control & and Research
Prevention Foundation
7672 3455.07 HHS/Centers for African Medical 4513 1217.07 $460,919
3455 3455.06 HHS/Centers for African Medical 2863 1217.06 $463,366
Table 3.3.16: